Business & Tech
Studies Suggest Medtronic's Infuse Not a Big Advance
Independent researchers said the Fridley med-tech giant's spine fusion device wasn't better than earlier treatment products, the Star Tribune reported.
Medtronic, Inc. got some bad news Monday: Scientists behind two separate, independent studies determined that Infuse, the company's product for spinal fusion, in not more effective than other treatments, according to the Star Tribune:
For years, spine surgeons praised Medtronic’s Infuse in helping to speed healing and reduce pain after spinal fusion surgeries, saying it was better than alternatives. Turns out, they were wrong, according to a review by Yale University. ...
Medtronic said Monday that the analyses confirm what the company has long claimed — that Infuse is a safe and effective product for patients, though it emphasized that it poses some risks that must be considered by patients and physicians.
Read the full article at startribune.com.
Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.
